1. Home
  2. MRUS vs APLE Comparison

MRUS vs APLE Comparison

Compare MRUS & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • APLE
  • Stock Information
  • Founded
  • MRUS 2003
  • APLE 2007
  • Country
  • MRUS Netherlands
  • APLE United States
  • Employees
  • MRUS N/A
  • APLE N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • APLE Real Estate Investment Trusts
  • Sector
  • MRUS Health Care
  • APLE Real Estate
  • Exchange
  • MRUS Nasdaq
  • APLE Nasdaq
  • Market Cap
  • MRUS 2.7B
  • APLE 2.7B
  • IPO Year
  • MRUS 2016
  • APLE 2015
  • Fundamental
  • Price
  • MRUS $43.06
  • APLE $11.88
  • Analyst Decision
  • MRUS Strong Buy
  • APLE Buy
  • Analyst Count
  • MRUS 13
  • APLE 4
  • Target Price
  • MRUS $86.85
  • APLE $17.25
  • AVG Volume (30 Days)
  • MRUS 872.0K
  • APLE 3.5M
  • Earning Date
  • MRUS 05-07-2025
  • APLE 05-01-2025
  • Dividend Yield
  • MRUS N/A
  • APLE 8.77%
  • EPS Growth
  • MRUS N/A
  • APLE 14.64
  • EPS
  • MRUS N/A
  • APLE 0.89
  • Revenue
  • MRUS $36,133,000.00
  • APLE $1,431,468,000.00
  • Revenue This Year
  • MRUS $26.81
  • APLE $3.11
  • Revenue Next Year
  • MRUS $23.85
  • APLE $2.71
  • P/E Ratio
  • MRUS N/A
  • APLE $13.39
  • Revenue Growth
  • MRUS N/A
  • APLE 6.52
  • 52 Week Low
  • MRUS $33.19
  • APLE $10.44
  • 52 Week High
  • MRUS $61.61
  • APLE $16.50
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 51.15
  • APLE 42.55
  • Support Level
  • MRUS $33.19
  • APLE $11.42
  • Resistance Level
  • MRUS $43.46
  • APLE $11.70
  • Average True Range (ATR)
  • MRUS 3.53
  • APLE 0.66
  • MACD
  • MRUS 0.34
  • APLE 0.05
  • Stochastic Oscillator
  • MRUS 80.53
  • APLE 54.96

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About APLE Apple Hospitality REIT Inc.

Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.

Share on Social Networks: